Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: A large cohort retrospective study
Authors:
- Xue HouXHXue Hou
- Shun LuSLShun Lu
- Huilan RaoHRHuilan Rao
- Jinghui HouJHJinghui Hou
- Rongzhen LuoRLRongzhen Luo
- He HuangHHHe Huang
- Hongyun ZhaoHZHongyun Zhao
- Hong JianHJHong Jian
- Zhiwei ChenZCZhiwei Chen
- Meilin LiaoMLMeilin Liao
- Xin WangXWXin Wang
- 1 January 2010
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 67 (1) , 114-119
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Metastasis gets site specificCancer Cell, 2005
- Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancerEuropean Journal of Cancer, 2004
- Long‐term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumorsCancer, 2004
- MMP expression profiling in recurred stage IB lung cancerOncogene, 2003
- Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinomaCancer, 2003
- Randomized Controlled Trial of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Nonmetastatic Prostate CancerJournal of Urology, 2003
- Elevated Serum Periostin Levels in Patients with Bone Metastases from Breast but not Lung CancerBreast Cancer Research and Treatment, 2003
- Cathepsin K mRNA and Protein Expression in Prostate Cancer ProgressionJournal of Bone and Mineral Research, 2003
- Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events. Myeloma Aredia Study Group.Journal of Clinical Oncology, 1998
- Skeletal complications of malignancyCancer, 1997